Decoding Primary Open-Angle Glaucoma: A Multi-Omics Approach to Identify Druggable Effector Genes
Investigative Ophthalmology & Visual Science · 2026
DOI: 10.1167/iovs.67.11.19 ↗At a glance
Journal article in Investigative Ophthalmology & Visual Science, 2026. Written by Jingze Guo and 16 co-authors. Institution: The First School of Clinical Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, People's Republic of China. Major MEDLINE topics: Glaucoma, Open-Angle, Quantitative Trait Loci, Polymorphism, Single Nucleotide, Genetic Predisposition to Disease. 74 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Purpose
Genomewide association studies (GWAS) have identified numerous primary open angle glaucoma (POAG) risk loci, yet most reside in non-coding regions with unclear function. Mapping these loci to effector genes can elucidate disease mechanisms, identify functionally conserved variants, improve cross-ancestry risk prediction by reducing population-specific noise, and uncover shared therapeutic targets.
Methods
Here, we integrate European POAG GWAS with six types of multi-omics molecular Quantitative Trait Locis (xQTLs) using multi-trait colocalization to identify candidate effector variants and evaluate their cross-population relevance using genetic risk score (GRS) analysis, and their therapeutic potential through drug target prioritization.
Results
We identified 25 POAG effector variants colocalized with at least one xQTLs. In non-European populations, effector variants showed stronger effect size correlations with Europeans than non-colocalized variants (Pearson r2 = African 0.85 vs. 0.71; East Asian 0.81 vs. 0.69; and Latin American 0.91 vs. 0.75). Effector variants also had smaller allele frequency variations across populations (average interquartile range [IQR] = 0.15 vs. 0.20). The genetic risk score based on effector variants performed comparably to the genome-wide significant single-nucleotide polymorphism (SNP)-based GRS in non-European populations. Drug prioritization identified zinc, copper, sunitinib, probucol, and astemizole as potential common therapeutic agents for POAG and its subtypes.
Conclusions
Our findings offer deeper insight into the molecular mechanisms underlying glaucoma and effector variants for developing more robust GRS models and broadly effective therapeutic strategies for POAG.
Subjects
MeSH terms (MEDLINE)
Authors and institutions
- The First School of Clinical Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, People's Republic of China.
- Department of Ophthalmology, Nanfang Hospital, Southern Medical University, Guangzhou, People's Republic of China.
- Department of Ophthalmology, Guangdong Provincial People's Hospital of Southern Medical University, Guangzhou, People's Republic of China.
- Department of Ophthalmology, Tohoku University Graduate School of Medicine, Sendai, Japan.
- Department of Ophthalmology, The Second People's Hospital of Foshan, Foshan, People's Republic of China.
- Institute of Ophthalmology, University College London, London, United Kingdom.
Cite
APA
Guo, J., Yao, Y., Lin, H., Niu, Y., Li, X., Liu, J., Liu, S., Qin, Y., Biradar, M., Shang, X., Zhu, Z., Plotnikov, D., Wang, H., Khawaja, A. P., He, M., Huang, Y., & Zhang, H. (2026). Decoding Primary Open-Angle Glaucoma: A Multi-Omics Approach to Identify Druggable Effector Genes. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.67.11.19
Vancouver
Guo J, Yao Y, Lin H, Niu Y, Li X, Liu J, et al. Decoding Primary Open-Angle Glaucoma: A Multi-Omics Approach to Identify Druggable Effector Genes. Investigative Ophthalmology & Visual Science. 2026. doi:10.1167/iovs.67.11.19
BibTeX
@article{Guo2026,
author = {Guo, Jingze and Yao, Ying and Lin, Hongliang and Niu, Yongyi and Li, Xue and Liu, Jing and Liu, Shunming and Qin, Yongjie and Biradar, Mahantesh and Shang, Xianwen and Zhu, Zhuoting and Plotnikov, Denis and Wang, Huan and Khawaja, Anthony P and He, Mingguang and Huang, Yu and Zhang, Hongyang},
title = {Decoding Primary Open-Angle Glaucoma: A Multi-Omics Approach to Identify Druggable Effector Genes},
journal = {Investigative Ophthalmology & Visual Science},
year = {2026},
doi = {10.1167/iovs.67.11.19}
}
EUVIMED